{"id":45316,"date":"2022-06-21T18:01:34","date_gmt":"2022-06-21T16:01:34","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/middle-east-precision-medicine-market-research-report-2022-collaborations-and-partnerships-across-value-chain-to-accelerate-market-entry-researchandmarkets-com\/"},"modified":"2022-06-21T18:01:34","modified_gmt":"2022-06-21T16:01:34","slug":"middle-east-precision-medicine-market-research-report-2022-collaborations-and-partnerships-across-value-chain-to-accelerate-market-entry-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/middle-east-precision-medicine-market-research-report-2022-collaborations-and-partnerships-across-value-chain-to-accelerate-market-entry-researchandmarkets-com\/","title":{"rendered":"Middle East Precision Medicine Market Research Report 2022 – Collaborations and Partnerships across Value Chain to Accelerate Market Entry – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Middle East Precision Medicine Market – Country Analysis: Focus on Ecosystem, Technology, Application, End User, and Country Data – Analysis and Forecast, 2022-2032”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe Middle East precision medicine market was estimated to be at $3,942.6 million in 2021, which is expected to grow with a CAGR of 7.37% and reach $8,620.0 million by 2032.\n<\/p>\n

\nThe Middle East precision medicine market is expected to witness high growth, attributed to the rising prevalence of chronic disease, advancement of sequencing technologies, reducing adverse drug reactions through pharmacogenomics tests, and potential to reduce the overall healthcare cost across the globe.\n<\/p>\n

\nThe continued significant investments by healthcare companies to meet industry demand and the growing adoption of precision medicine among major end users are the major factors propelling the growth of the Middle East precision medicine market.\n<\/p>\n

\nMarket Lifecycle Stage<\/strong>\n<\/p>\n

\nPrecision medicine refers to the medicine developed as per an individual’s genetic profile. It provides guidance regarding the prevention, diagnosis, and treatment of diseases.\n<\/p>\n

\nThe segmentation of the population is done depending on the genome structure of individuals and their compatibility with a specific drug molecule. In the precision medicine market, the application of molecular biology is to study the cause of a patient’s disease at the molecular level so that target-based therapies or individualized therapies can be applied to cure the patient’s health-related problems.\n<\/p>\n

\nThis industry is gaining traction owing to the growing awareness about healthcare among individuals, the integration of smart devices such as smartphones and tablets into healthcare, and the increasing collaborations and agreements of information technology (IT) firms with the diagnostics and biopharmaceutical companies for the development of precision diagnostic tools.\n<\/p>\n

\nThe growth of the precision medicine market over the last few years has been monumental. New technologies are rapidly being introduced, expanding the arsenal of tools accessible to support the development and adoption of precision medicine solutions over “one-size-fits-all” therapies.\n<\/p>\n

\nAdvancements in gene therapies, cell therapies, molecular biomarker analysis, and companion diagnostics have the potential to transform medicine and increase the ability to treat and cure several intractable diseases. Advances in sequencing technologies and non-invasive diagnostics, such as liquid biopsy and non-invasive prenatal testing (NIPT), have facilitated the acquisition of real-time data and gained interest for their usage in acquiring the data by exhibiting the biology of tumors and metastatic tissues.\n<\/p>\n

\nImpact<\/strong>\n<\/p>\n

\nThe presence of major service providers of precision medicine products in Middle East regions has a major impact on the market. For instance, Illumina, Inc. provides NovaSeq 6000 S2, Reagent Kit, NovaSeq 6000 S4 reagent kit, and NovaSeq Xp 4-lane kit in the Middle East.\n<\/p>\n

\nCompanies such as F. Hoffmann-La Roche Ltd provide foundation one liquid. The services are a reliable and convenient way to expand in-house resources with expertise and perfectly tailored bioinformatics services that ensure quality results. The presence of these companies has a positive impact on market growth.\n<\/p>\n

\nImpact of COVID-19<\/strong>\n<\/p>\n

\nThe current Middle East precision medicine market study comprises products and applications utilized to provide beneficial effects to specific health benefits and treatments. Since the market is primarily application and ecosystem-dominated, the COVID-19 pandemic had a low impact on the growth or the revenue generated from the market.\n<\/p>\n

\nThe current market assessment has considered information provided by key opinion leaders in the market, from the supply side as well as the demand side. A majority of the products, such as kits and assays in the market, are used for infectious disease applications. In addition, infectious diseases are playing an important role in the growth of the market.\n<\/p>\n

\nRecent Developments in Middle East Precision Medicine Market<\/strong>\n<\/p>\n